Almirall maintains guidance despite slight stock market decline

Pharmaceutical company Almirall records a slight stock price decline on May 11, but reaffirms the validity of its financial targets.

Published 9sem1 sourceupdated 9sem

≈ 22sSpeed

The fact

The Spanish health group justifies maintaining its guidance through the strength of its product portfolio and commercial outlook.

This confirmation partially reassures investors despite current market pressures.

Click the link to read an article on the topic:

Explore this topic

Auto-synthesis from 1 media source · identified on May 11, 2026